Security key
H5870P102
Oculis Holding AG - Ordinary Shares, par value CHF 0.01 per share (OCS)
CUSIP: H5870P102
Q2 2026 13F Holders as of 30 Jun 2026
- Security type / class
- Equity / Ordinary Shares, par value CHF 0.01 per share
- Total 13F shares
- 375,000
- Total 13F value
- $5,201,000
- Share change
- +152,133
- SEC-reported price per share
- $13.87
- Number of holders
- 1
- Value change
- +$2,109,983
- Number of buys
- 1
- Shares outstanding
- 58,900,797
Holder snapshot
5 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2026
Institutions
1
Top holders
1
OCS full security history
Ownership snapshot
Full 13F holder table
Previous quarter: Q1 2026
Oculis Holding AG SEC filings
Oculis Holding AG company facts
Broader feeds
Reporting periods
Holder history for CUSIP H5870P102
Recent filing periods:
Ownership snapshot
Top reported holders of OCS - Oculis Holding AG - Ordinary Shares, par value CHF 0.01 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
7. Cooperative Ua Lsp
Disclosed value leader
7. Cooperative Ua Lsp
Comparable rows
15/15
Latest evidence
31 Mar 2026
13D/G
13F
Lead comparable stake: 12%
13D/G row: 7. Cooperative Ua Lsp
Showing 1-6 of 15 holder rows.
Quick read
7. Cooperative Ua Lsp leads the comparable SEC ownership view at 12%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens 7. Cooperative Ua Lsp's linked filing trail.
Comparable ownership
Top 5
7. Cooperative Ua Lsp
12%
Pivotal bioVenture Partners Fund ...
4.9%
BVCF IV, L.P.
4.1%
EQT Fund Management S.a r.l.
10%
Gildi - lifeyrissjodur
4.1%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| 7. Cooperative Ua Lsp |
13D/G
LSP 7 Cooperatieve U.A.
|
12%
|
$184,808,317
6,950,294 shares
|
+$31,838,866 | 31 Mar 2026 |
| Pivotal bioVenture Partners Fund I, L.P. |
13D/G
Nan Fung Group Holdings Limited
|
4.9%
|
$49,946,544
2,815,476 shares
|
$0 | 30 Sep 2025 |
| BVCF IV, L.P. |
13D/G
|
4.1%
|
$73,082,691
2,436,902 shares
|
+$7,350,309 | 13 Feb 2026 |
| EQT Fund Management S.a r.l. |
13F
Company
|
10%
|
$156,888,817
5,900,294 shares
|
— | 31 Mar 2026 |
| Gildi - lifeyrissjodur |
13F
Company
|
4.1%
|
$64,316,401
2,430,401 shares
|
— | 31 Mar 2026 |
| Aberdeen Group plc |
13F
Company
|
3%
|
$46,451,294
1,746,946 shares
|
— | 31 Mar 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
1
Shares
375,000
Rows available
1
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2026 vs Q1 2026 Across Filers
Q1 2026 holders
57
Q2 2026 holders
1
Holder diff
-56
| Investor | Q1 2026 Shares | Q2 2026 Shares | Share Diff | Share Chg % | Q1 2026 value | Q2 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend